Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.

Bergman H, Wichmann T, DeLong MR.

Science. 1990 Sep 21;249(4975):1436-8.

PMID:
2402638
3.

Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys.

Benazzouz A, Gross C, Féger J, Boraud T, Bioulac B.

Eur J Neurosci. 1993 Apr 1;5(4):382-9.

PMID:
8261116
4.

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.

Bergman H, Wichmann T, Karmon B, DeLong MR.

J Neurophysiol. 1994 Aug;72(2):507-20.

PMID:
7983515
5.

Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.

Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H.

J Neurosci. 2002 Jun 1;22(11):4639-53.

6.

Computational physiology of the basal ganglia in Parkinson's disease.

Rivlin-Etzion M, Elias S, Heimer G, Bergman H.

Prog Brain Res. 2010;183:259-73. doi: 10.1016/S0079-6123(10)83013-4.

PMID:
20696324
7.

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, Crossman AR.

Neuroscience. 1989;32(1):213-26.

PMID:
2586750
8.

Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).

Taylor JR, Elsworth JD, Roth RH, Sladek JR Jr, Redmond DE Jr.

Neuroscience. 1997 Dec;81(3):745-55.

PMID:
9316026
9.
11.

Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.

Elsworth JD, Taylor JR, Sladek JR Jr, Collier TJ, Redmond DE Jr, Roth RH.

Neuroscience. 2000;95(2):399-408.

PMID:
10658619
12.
13.

Presymptomatic revelation of experimental parkinsonism.

Bezard E, Boraud T, Bioulac B, Gross CE.

Neuroreport. 1997 Jan 20;8(2):435-8.

PMID:
9080424
14.
15.

Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment.

Benazzouz A, Boraud T, Féger J, Burbaud P, Bioulac B, Gross C.

Mov Disord. 1996 Nov;11(6):627-32.

PMID:
8914087
16.

Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate.

Aziz TZ, Peggs D, Agarwal E, Sambrook MA, Crossman AR.

Br J Neurosurg. 1992;6(6):575-82.

PMID:
1361741
17.

Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys.

Taylor JR, Elsworth JD, Sladek JR Jr, Collier TJ, Roth RH, Redmond DE Jr.

Cell Transplant. 1995 Jan-Feb;4(1):13-26.

PMID:
7728327
18.

[Spontaneous saccades in MPTP-induced hemi-parkinsonian monkeys].

Usui S, Fukuda H, Hikosaka O.

Rinsho Shinkeigaku. 1990 Nov;30(11):1181-9. Japanese.

PMID:
2085922
19.

The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.

Jenner P, Marsden CD.

J Neural Transm Suppl. 1986;20:11-39. Review.

PMID:
3091760
20.

Developing a stable bilateral model of parkinsonism in rhesus monkeys.

Smith RD, Zhang Z, Kurlan R, McDermott M, Gash DM.

Neuroscience. 1993 Jan;52(1):7-16.

PMID:
8433810

Supplemental Content

Support Center